Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darrell J Triulzi

Showing results (121-130 of 160) with videos related to

Pageof 16
Sort By:
Vox Sanguinis|January 25, 2021
The risk to future pregnancies of transfusing Rh(D)-negative females of childbearing potential with Rh(D)-positive red blood cells during trauma resuscitation is dependent on their age at transfusionJansen N Seheult, Michelle N Stram, Thomas Pearce, et al.
Transfusion|September 9, 2020
NT-proBNP levels in the identification and classification of pulmonary transfusion reactionsNareg H Roubinian, Dhuly Chowdhury, Jeanne E Hendrickson, et al.
Trauma Surgery & Acute Care Open|January 10, 2024
Therapeutic plasma exchange is feasible and tolerable in severely injured patients with trauma-induced coagulopathySarah A Moore, Marian A Rollins-Raval, Jennifer M Gillette, et al.
British Journal of Haematology|April 21, 2023
Considering equality in transfusion medicine practiceMark H Yazer, José R Díaz-Valdés, Darrell J Triulzi, et al.
Transfusion|October 12, 2019
Association of donor age, body mass index, hemoglobin, and smoking status with in-hospital mortality and length of stay among red blood cell-transfused recipientsNareg H Roubinian, Matt Westlake, Elizabeth M St Lezin, et al.
Transfusion|November 15, 2018
Prevalence and risk factors for RBC alloantibodies in blood donors in the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III)Matthew S Karafin, Sylvia Tan, Christopher A Tormey, et al.
Critical Care Medicine|January 5, 2018
Contemporary Risk Factors and Outcomes of Transfusion-Associated Circulatory OverloadNareg H Roubinian, Jeanne E Hendrickson, Darrell J Triulzi, et al.
Transfusion|August 20, 2014
Trends in red blood cell transfusion and 30-day mortality among hospitalized patientsNareg H Roubinian, Gabriel J Escobar, Vincent Liu, et al.
Blood Advances|August 31, 2022
Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopeniaAnton Ilich, Terry B Gernsheimer, Darrell J Triulzi, et al.
Blood|June 6, 2022
Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trialTerry B Gernsheimer, Siobhan P Brown, Darrell J Triulzi, et al.
Pageof 16

Showing results (121-130 of 160) with videos related to

Sort By:
Pageof 16
Vox Sanguinis|January 25, 2021
The risk to future pregnancies of transfusing Rh(D)-negative females of childbearing potential with Rh(D)-positive red blood cells during trauma resuscitation is dependent on their age at transfusionJansen N Seheult, Michelle N Stram, Thomas Pearce, et al.
Transfusion|September 9, 2020
NT-proBNP levels in the identification and classification of pulmonary transfusion reactionsNareg H Roubinian, Dhuly Chowdhury, Jeanne E Hendrickson, et al.
Trauma Surgery & Acute Care Open|January 10, 2024
Therapeutic plasma exchange is feasible and tolerable in severely injured patients with trauma-induced coagulopathySarah A Moore, Marian A Rollins-Raval, Jennifer M Gillette, et al.
British Journal of Haematology|April 21, 2023
Considering equality in transfusion medicine practiceMark H Yazer, José R Díaz-Valdés, Darrell J Triulzi, et al.
Transfusion|October 12, 2019
Association of donor age, body mass index, hemoglobin, and smoking status with in-hospital mortality and length of stay among red blood cell-transfused recipientsNareg H Roubinian, Matt Westlake, Elizabeth M St Lezin, et al.
Transfusion|November 15, 2018
Prevalence and risk factors for RBC alloantibodies in blood donors in the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III)Matthew S Karafin, Sylvia Tan, Christopher A Tormey, et al.
Critical Care Medicine|January 5, 2018
Contemporary Risk Factors and Outcomes of Transfusion-Associated Circulatory OverloadNareg H Roubinian, Jeanne E Hendrickson, Darrell J Triulzi, et al.
Transfusion|August 20, 2014
Trends in red blood cell transfusion and 30-day mortality among hospitalized patientsNareg H Roubinian, Gabriel J Escobar, Vincent Liu, et al.
Blood Advances|August 31, 2022
Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopeniaAnton Ilich, Terry B Gernsheimer, Darrell J Triulzi, et al.
Blood|June 6, 2022
Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trialTerry B Gernsheimer, Siobhan P Brown, Darrell J Triulzi, et al.
Pageof 16